Document ID: FMCSA-2015-0322-0001
Agency: fmcsa
Document Type: Notice
Title: Qualification of Drivers; Exemption Applications: Epilepsy and Seizure Disorders
Posted Date: 2016-05-09T04:00Z

[Federal Register Volume 81, Number 89 (Monday, May 9, 2016)]
[Notices]
[Pages 28131-28134]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-10795]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2015-0322]

Qualification of Drivers; Exemption Applications; Epilepsy and 
Seizure Disorders

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department 
of Transportation (DOT).

ACTION: Notice of applications for exemptions; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 27 individuals 
for an exemption from the prohibition against persons with a clinical 
diagnosis of epilepsy or any other condition that is likely to cause a 
loss of consciousness or any loss of ability to operate a commercial 
motor vehicle (CMV) in interstate commerce. If granted, the exemptions 
would enable these

[[Page 28132]]

individuals who have had one or more seizures and are taking anti-
seizure medication to operate CMVs for up to 2 years in interstate 
commerce.

DATES: Comments must be received on or before June 8, 2016.

ADDRESSES: You may submit comments bearing the Federal Docket 
Management System (FDMS) Docket No. FMCSA-2015-0322 using any of the 
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting 
comments.
     Mail: Docket Management Facility; U.S. Department of 
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor, 
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140, 
1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., 
Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    Instructions: Each submission must include the Agency name and the 
docket numbers for this notice. Note that all comments received will be 
posted without change to http://www.regulations.gov, including any 
personal information provided. Please see the Privacy Act heading below 
for further information.
    Docket: For access to the docket to read background documents or 
comments, go to http://www.regulations.gov at any time or Room W12-140 
on the ground level of the West Building, 1200 New Jersey Avenue SE., 
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, 
except Federal holidays. The Federal Docket Management System (FDMS) is 
available 24 hours each day, 365 days each year. If you want 
acknowledgment that we received your comments, please include a self-
addressed, stamped envelope or postcard or print the acknowledgement 
page that appears after submitting comments on-line.
    Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits 
comments from the public to better inform its rulemaking process. DOT 
posts these comments, without edit, including any personal information 
the commenter provides, to http://www.regulations.gov as described in 
the system records notice (DOT/ALL-14 FDMS), which can be reviewed at 
http://www.dot.gov/privacy.

FOR FURTHER INFORMATION CONTACT: Christine A. Hydock, Chief, Medical 
Programs Division, (202) 366-4001, or via email at 
fmcsamedical@dot.gov, or by letter to FMCSA, Room W64-113, Department 
of Transportation, 1200 New Jersey Avenue SE., Washington, DC 20590-
0001. Office hours are from 8:30 a.m. to 5 p.m., Monday through Friday, 
except Federal holidays.

SUPPLEMENTARY INFORMATION: 

I. Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption 
for up to a 2-year period if it finds ``such exemption would likely 
achieve a level of safety that is equivalent to or greater than the 
level that would be achieved absent such exemption.'' The statutes 
allow the Agency to renew exemptions at the end of the 2-year period. 
The 27 individuals listed in this notice have requested an exemption 
from the epilepsy prohibition in 49 CFR 391.41(b)(8), which applies to 
drivers who operate CMVs in interstate commerce. Accordingly, the 
Agency will evaluate the qualifications of each applicant to determine 
whether granting the exemption will achieve the required level of 
safety mandated by statute.
    The physical qualification standard for drivers regarding epilepsy 
found in 49 CFR 391.41(b)(8) states that a person is physically 
qualified to drive a CMV if that person

    Has no established medical history or clinical diagnosis of 
epilepsy or any other condition which is likely to cause the loss of 
consciousness or any loss of ability to control a CMV.

    In addition to the regulations, FMCSA has published advisory 
criteria to assist medical examiners in determining whether drivers 
with certain medical conditions are qualified to operate a CMV in 
interstate commerce. The advisory criteria found in Appendix A to 49 
CFR 391.41, states that

    If an individual has had a sudden episode of a non-epileptic 
seizure or loss of consciousness of unknown cause that did not 
require anti-seizure medication, the decision whether that person's 
condition is likely to cause the loss of consciousness or loss of 
ability to control a CMV should be made on an individual basis by 
the medical examiner in consultation with the treating physician. 
Before certification is considered, it is suggested that a 6-month 
waiting period elapse from the time of the episode. Following the 
waiting period, it is suggested that the individual have a complete 
neurological examination. If the results of the examination are 
negative and anti-seizure medication is not required, then the 
driver may be qualified.
    In those individual cases where a driver had a seizure or an 
episode of loss of consciousness that resulted from a known medical 
condition (e.g., drug reaction, high temperature, acute infectious 
disease, dehydration, or acute metabolic disturbance), certification 
should be deferred until the driver has recovered fully from that 
condition, has no existing residual complications, and is not taking 
anti-seizure medication.
    Drivers who have a history of epilepsy/seizures, off anti-
seizure medication and seizure-free for 10 years, may be qualified 
to operate a CMV in interstate commerce. Interstate drivers with a 
history of a single unprovoked seizure may be qualified to drive a 
CMV in interstate commerce if seizure-free and off anti-seizure 
medication for a 5-year period or more.

    As a result of medical examiners misinterpreting advisory criteria 
as regulation, numerous drivers have been prohibited from operating a 
CMV in interstate commerce based on the fact that they have had one or 
more seizures and are taking anti-seizure medication, rather than an 
individual analysis of their circumstances by a qualified medical 
examiner based on the physical qualification standards and medical best 
practices.

II. Qualifications of Applicants

Hamilton Barnard

    Mr. Barnard is a 38 year-old driver in California. He has a history 
of a seizure disorder and has remained seizure free since 2005. He 
takes anti-seizure medication with the dosage and frequency remaining 
the same since that time. His physician states that he is supportive of 
Mr. Barnard receiving an exemption.

William E. Beaver

    Mr. Beaver is a 50 year-old class A CDL holder in Minnesota. He has 
a history of a single seizure in January 2015, likely secondary to 
cyclosporine use and posterior reversible encephalopathy syndrome. He 
discontinued taking anti-seizure in May 2015. His physician states that 
he is supportive of Mr. Beaver receiving an exemption.

Paul V. Carlson

    Mr. Carlson is a 38 year-old driver in Minnesota. He has a history 
of a single seizure following brain surgery for treatment of an 
obstructive hydrocephalus ventricular colloid cyst in 2015. He takes 
anti-seizure medication with the dosage and frequency remaining the 
same since that time. His physician states that he is supportive of Mr. 
Carlson receiving an exemption.

Edward J. Carder Jr.

    Mr. Carder is a 37 year-old driver in Ohio. He has a history of a 
single seizure in 2010. He takes anti-seizure medication with the 
dosage and

[[Page 28133]]

frequency remaining the same since that time. His physician states that 
he is supportive of Mr. Carder receiving an exemption.

Timothy M. Crampton

    Mr. Crampton is a 24 year-old driver in Connecticut. He has a 
history of epilepsy and has remained seizure free since 2002. He takes 
anti-seizure medication with the dosage and frequency remaining the 
same since that time. His physician states that he is supportive of Mr. 
Crampton receiving an exemption.

Henry Dennis Counts Jr.

    Mr. Counts is a 39 year-old driver in Maryland. He has a history of 
a seizure disorder and has remained seizure free since 2003. He takes 
anti-seizure medication with the dosage and frequency remaining the 
same since 2006. His physician states that he is supportive of Mr. 
Counts receiving an exemption.

Tommy Joe Cox

    Mr. Cox is a 53 year-old class B CDL holder in Kentucky. He has a 
history of epilepsy and has remained seizure free since 2014. He takes 
anti-seizure medication with the dosage and frequency remaining the 
same since that time. His physician states that he is supportive of Mr. 
Cox receiving an exemption.

Michael D. Davis

    Mr. Davis is a 47 year-old class A CDL holder in Maine. He has a 
history of a seizure disorder and has remained seizure free since 1998. 
He takes anti-seizure medication with the dosage and frequency 
remaining the same since 2002. His physician states that he is 
supportive of Mr. Davis receiving an exemption.

William Garvin

    Mr. Garvin is a 38 year-old driver in New Hampshire. He has a 
history of a seizure in 2015. He takes anti-seizure medication with the 
dosage and frequency remaining the same since that time. His physician 
states that she is supportive of Mr. Garvin receiving an exemption.

Charlie E. Getchell

    Mr. Getchell is a 57 year-old class B CDL holder in Wisconsin. He 
has a history of a single seizure and has remained seizure free since 
1986. He takes anti-seizure medication with the dosage and frequency 
remaining the same since that time. His physician states that he is 
supportive of Mr. Getchell receiving an exemption.

Dennis R. Giles

    Mr. Giles is a 56 year-old class B CDL holder in Indiana. He has a 
history of a single seizure in 2010 and has remained seizure free since 
that time. He takes anti-seizure medication with the dosage and 
frequency remaining the same since that time. His physician states that 
he is supportive of Mr. Giles receiving an exemption.

Jeremiah Gonzales

    Mr. Gonzales is a 34 year-old class A CDL holder in Colorado. He 
has a history of a seizure disorder and has remained seizure free since 
2009. He takes anti-seizure medication with the dosage and frequency 
remaining the same since 2013. His physician states that he is 
supportive of Mr. Gonzales receiving an exemption.

Robert W. Goddard

    Mr. Goddard is a 53 year-old class B CDL holder in New Hampshire. 
He has a history of a seizure disorder and has remained seizure free 
since 2006. He takes anti-seizure medication with the dosage and 
frequency remaining the same since 2013. His physician states that he 
is supportive of Mr. Goddard receiving an exemption.

Roderick L. Haslip

    Mr. Haslip is a 54 year-old class A CDL holder in New York. He has 
a history of a seizure disorder and has remained seizure free since 
2010. He takes anti-seizure medication with the dosage and frequency 
remaining the same since that time. His physician states that he is 
supportive of Mr. Haslip receiving an exemption.

Larry G. Hediger

    Mr. Hediger is a 59 year-old class A CDL holder in Illinois. He has 
a history of epilepsy and has remained seizure free since 2004. He 
takes anti-seizure medication with the dosage and frequency remaining 
the same since 2006. His physician states that he is supportive of Mr. 
Hediger receiving an exemption.

Martin Lancaster

    Mr. Lancaster is a 51 year-old driver in Maine. He has a history of 
a seizure disorder and has remained seizure free since 2001. He takes 
anti-seizure medication with the dosage and frequency remaining the 
same since that time. His physician states that he is supportive of Mr. 
Lancaster receiving an exemption.

Philip A. Logan

    Mr. Logan is a 35 year-old driver in South Carolina. He has a 
history of a seizure disorder and has remained seizure free since 1998. 
He takes anti-seizure medication with the dosage and frequency 
remaining the same since that time. His physician states that he is 
supportive of Mr. Logan receiving an exemption.

Eric J. McVetty

    Mr. McVetty is a 29 year-old class B CDL holder in New Hampshire. 
He has a history of a seizure disorder and has remained seizure free 
since 2005. He takes anti-seizure medication with the dosage and 
frequency remaining the same since that time. His physician states that 
he is supportive of Mr. McVetty receiving an exemption.

Doug William Outfleet

    Mr. Outfleet is a 55 year-old driver in California. He has a 
history of a seizure disorder and has remained seizure free since 2010. 
He takes anti-seizure medication with the dosage and frequency 
remaining the same since that time. His physician states that he is 
supportive of Mr. Outfleet receiving an exemption.

David J. Parris

    Mr. Parris is a 22 year-old driver in Illinois. He has a history of 
a seizure disorder and has remained seizure free since 2012. He takes 
anti-seizure medication with the dosage and frequency remaining the 
same since that time. His physician states that he is supportive of Mr. 
Parris receiving an exemption.

Donald John Richmond

    Mr. Richmond is a 63 year-old driver in South Carolina. He has a 
history of a seizure disorder and has remained seizure free since 1980. 
He takes anti-seizure medication with the dosage and frequency 
remaining the same since 2001. His physician states that he is 
supportive of Mr. Richmond receiving an exemption.

Shawn E. Sands

    Mr. Sands is a 32 year-old driver in Illinois. He has a history of 
epilepsy and has remained seizure free since 2009. He takes anti-
seizure medication with the dosage and frequency remaining the same 
since that time. His physician states that he is supportive of Mr. 
Sands receiving an exemption.

Robert B.Skinner

    Mr. Skinner is a 43 year-old driver in Ohio. He has a history of a 
brain tumor and has remained seizure free since 2007. He takes anti-
seizure medication with the dosage and frequency remaining the same 
since that time. His

[[Page 28134]]

physician states that he is supportive of Mr. Skinner receiving an 
exemption.

Shaen Smith

    Mr. Smith is a 47 year-old driver in Minnesota. He has a history of 
epilepsy and has remained seizure free since 1998. He takes anti-
seizure medication with the dosage and frequency remaining the same 
since 2013. His physician states that he is supportive of Mr. Smith 
receiving an exemption.

Kevin Lee Sprinkle

    Mr. Sprinkle is a 35 year-old class A CDL holder in North Carolina. 
He has a history of juvenile epilepsy and has remained seizure free 
since 2005. He takes anti-seizure medication with the dosage and 
frequency remaining the same since that time. His physician states that 
he is supportive of Mr. Sprinkle receiving an exemption.

Patrick Trimbo

    Mr. Trimbo is a 53 year-old class A CDL holder in Minnesota. He has 
a history of a seizure disorder and has remained seizure free since 
1996. He takes anti-seizure medication with the dosage and frequency 
remaining the same since 2008. His physician states that he is 
supportive of Mr. Trimbo receiving an exemption.

Alan Washabaugh

    Mr. Washabaugh is a 57 year-old class A CDL holder in Pennsylvania. 
He has a history of a seizure disorder and has remained seizure free 
since 1996. He takes anti-seizure medication with the dosage and 
frequency remaining the same since that time. His physician states that 
he is supportive of Mr. Washabaugh receiving an exemption.

III. Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests 
public comment from all interested persons on the exemption petitions 
described in this notice. We will consider all comments received before 
the close of business on the closing date indicated in the date section 
of the notice.

IV. Submitting Comments

    You may submit your comments and material online or by fax, mail, 
or hand delivery, but please use only one of these means. FMCSA 
recommends that you include your name and a mailing address, an email 
address, or a phone number in the body of your document so that FMCSA 
can contact you if there are questions regarding your submission.
    To submit your comment online, go to http://www.regulations.gov and 
in the search box insert the docket number ``FMCSA-2015-0322'' and 
click the search button. When the new screen appears, click on the blue 
``Comment Now!'' button on the right hand side of the page. On the new 
page, enter information required including the specific section of this 
document to which each comment applies, and provide a reason for each 
suggestion or recommendation. If you submit your comments by mail or 
hand delivery, submit them in an unbound format, no larger than 8\1/2\ 
by 11 inches, suitable for copying and electronic filing. If you submit 
comments by mail and would like to know that they reached the facility, 
please enclose a stamped, self-addressed postcard or envelope. We will 
consider all comments and materials received during the comment period. 
FMCSA may issue a final determination any time after the close of the 
comment period.

V. Viewing Comments and Documents

    To view comments, as well as any documents mentioned in this 
preamble, go to http://www.regulations.gov and in the search box insert 
the docket number FMCSA-2015-0322 and click ``Search.'' Next, click 
``Open Docket Folder'' and you will find all documents and comments 
related to this notice.

    Issued on: April 29, 2016.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2016-10795 Filed 5-6-16; 8:45 am]
 BILLING CODE 4910-EX-P